ZENCORE NEWS & EVENTS

News & Events News & Events

Zencore News
Breaking News | Zencore Biologics Successfully Obtains the “Drug Production License,” Reaching an Important Milestone in Its Growth
2025-01-16

Breaking News | Zencore Biologics Successfully Obtains the “Drug Production License,” Reaching an Important Milestone in Its Growth

View details →
Congratulations | Novotel Biotech Approved to Conduct Phase I Clinical Trial of Recombinant Human Hyaluronidase Injection
2024-12-31

Congratulations | Novotel Biotech Approved to Conduct Phase I Clinical Trial of Recombinant Human Hyaluronidase Injection

View details →
Zencore's "Hyaluronidase" Pharmaceutical Excipient Registered with NMPA
2024-12-22

Zencore's "Hyaluronidase" Pharmaceutical Excipient Registered with NMPA

View details →
Congratulations to Zencore Biologics for being awarded the title of "Shanghai Key Service Unicorn Enterprise"
2024-04-28

Congratulations to Zencore Biologics for being awarded the title of "Shanghai Key Service Unicorn Enterprise"

View details →
Congratulations to D2M Biotherapeutics on the NMPA Approval for the First Proprietary Pipeline Product DM919
2024-04-12

Congratulations to D2M Biotherapeutics on the NMPA Approval for the First Proprietary Pipeline Product DM919

View details →
Strategic Collaboration | Zencore Biologics Signed a Strategic Cooperation Agreement with Apeloa Pharmaceutical
2024-03-06

Strategic Collaboration | Zencore Biologics Signed a Strategic Cooperation Agreement with Apeloa Pharmaceutical

View details →
Warmly welcome the delegation from Shanghai Municipal Commission of Economy and Informatization to visit Zencore Biologics
2024-02-02

Warmly welcome the delegation from Shanghai Municipal Commission of Economy and Informatization to visit Zencore Biologics

View details →
Amazing Recap: 2024 Zencore Biologics Annual Gala and Awards Ceremony Successfully Concludes
2024-02-02

Amazing Recap: 2024 Zencore Biologics Annual Gala and Awards Ceremony Successfully Concludes

View details →
Congratulations to D2M Biotherapeutics on the IND Approval for the First Proprietary Pipeline Product DM919
2023-12-29

Congratulations to D2M Biotherapeutics on the IND Approval for the First Proprietary Pipeline Product DM919

View details →